Related Articles
Primary central nervous system lymphoma treated with high‑dose methotrexate and rituximab: A single‑institution experience
Immunochemotherapy for primary central nervous system lymphoma with rituximab, methotrexate, cytarabine and dexamethasone: Retrospective analysis of 18 cases
Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma
Comparison of the outcomes of patients with primary central nervous system lymphoma between the neurosurgery and hematology/oncology departments based on the relative dose intensity of methotrexate
Management of refractory or relapsed primary central nervous system lymphoma (Review)